THOMAS; Marian

Patent Applications and Registrations

Patent applications and USPTO patent grants for THOMAS; Marian.The latest application filed is for "combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist".

Company Profile

1.4.17

THOMAS; Marian - Ware GB
Thomas; Marian - Hertfordshire GB
Thomas; Marian - Research Triangle Park NC
Thomas, Marian - Ware Hertfordshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist App 20220047565 - BAKER; Darrell ; et al.	2022-02-17
Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyet- hyl}-2-(hydroxymethyl) phenol Grant 11,116,721 - Baker , et al. September 14, 2	2021-09-14
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist Grant 11,090,294 - Baker , et al. August 17, 2	2021-08-17
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist App 20200171009 - BAKER; Darrell ; et al.	2020-06-04
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist App 20180008582 - BAKER; Darrell ; et al.	2018-01-11
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist Grant 9,750,726 - Baker , et al. September 5, 2	2017-09-05
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist App 20160095840 - BAKER; Darrell ; et al.	2016-04-07
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist App 20120309725 - Baker; Darrell ; et al.	2012-12-06
Pharmaceutical Formulations Comprising 4-hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol App 20110319371 - Baker; Darrell ; et al.	2011-12-29
Pharmaceutical Formulations App 20100093866 - Monteith; Michael John ; et al.	2010-04-15
Pharmaceutical formulations comprising magnesium stearate App 20060239932 - Monteith; Michael John ; et al.	2006-10-26
Pharmaceutical formulations App 20060233716 - Monteith; Michael John ; et al.	2006-10-19
Pharmaceutical formulations App 20060210485 - Thomas; Marian	2006-09-21
Pharmaceutical formulations App 20050201949 - Monteith, Michael John ; et al.	2005-09-15
Novel aqueous anti-inflammatory pharmaceutical formulation App 20040044035 - Armour, Duncan Robert ; et al.	2004-03-04
Pharmaceutical anti-inflammatory aerosol formulation App 20040039021 - Armour, Duncan Robert ; et al.	2004-02-26
Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist App 20040037784 - Armour, Duncan Robert ; et al.	2004-02-26
Novel pharmaceutical formulation suitable for nebulisation App 20040039020 - Armour, Duncan ; et al.	2004-02-26
Novel pharmaceutical formulation suitable for nebulisation App 20040034058 - Armour, Duncan ; et al.	2004-02-19
Novel aqueous anti-inflammatory pharmaceutical formulation App 20040034062 - Armour, Duncan Robert ; et al.	2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.